Guangchun He

Hunan Normal University

H指数:17

被引数:1,322

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glutamine Synthetase: Spotlighting the Emerging Roles in Tumor Progression and Therapeutic Avenues

谷氨酰胺合酶：聚焦其在肿瘤进展和治疗方法中的新兴作用

Critical Reviews in Oncology/Hematology

IF0

2026-02-280

PRE

Multi-omics characterization of C4orf19 in HNSCC: constructing prognostic signatures for immunotherapy and chemotherapy response prediction

BMC Cancer

IF3.4

2026-01-300

OAAI

Neutrophil Extracellular Traps in Breast Cancer: Roles in Metastasis and Beyond

乳腺癌中的中性粒细胞胞外诱捕网: 在转移及其他方面的作用

JOURNAL OF CANCER

IF3.2

2024-01-011

OAAI

Filamentous Actin in the Nucleus in Triple-Negative Breast Cancer Stem Cells: A Key to Drug-Induced Nucleolar Stress and Stemness Inhibition?

JOURNAL OF CANCER

IF3.2

2024-01-010

OAAI

Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance

三阴性乳腺癌中的中性粒细胞: 一个被低估的参与者，其重要性日益得到认可

BREAST CANCER RESEARCH

IF5.6

2023-07-2618

OAAI

Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2022-01-319

OAAI

Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells

JOURNAL OF CANCER

IF3.2

2022-01-015

OAAI

Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins

洛伐他汀通过调节细胞骨架相关蛋白抑制三阴性乳腺癌干细胞的EMT和转移

FRONTIERS IN ONCOLOGY

IF3.3

2021-06-0425

OAAI

Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis

JOURNAL OF CANCER

IF3.2

2021-01-0190

OAAI

CD133 peptide-conjugated pyropheophorbide-a as a novel photosensitizer for targeted photodynamic therapy in colorectal cancer stem cells

BIOMATERIALS SCIENCE

IF5.7

2021-01-0117

PRE

Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem Cells

逆转HER2阴性: 洛伐他汀在三阴性乳腺癌干细胞中的意外作用

JOURNAL OF CANCER

IF3.2

2020-01-0110

OAAI

Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis

BMC CANCER

IF3.4

2019-08-2322

OAAI

Cerasomal Lovastatin Nanohybrids for Efficient Inhibition of Triple-Negative Breast Cancer Stem Cells To Improve Therapeutic Efficacy

Cerasomal洛伐他汀纳米杂化物有效抑制三阴性乳腺癌干细胞以提高治疗效果

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2018-02-1923

PREAI

Nucleolar stress: is there a reverse version?

JOURNAL OF CANCER

IF3.2

2018-01-0113

OAAI

Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma

JOURNAL OF CANCER

IF3.2

2017-01-0136

OAAI

Identification of Nucleobindin-2 as a Potential Biomarker for Breast Cancer Metastasis Using iTRAQ-based Quantitative Proteomic Analysis

JOURNAL OF CANCER

IF3.2

2017-01-0126

OAAI

Effects of Lovastatin on MDA-MB-231 Breast Cancer Cells: An Antibody Microarray Analysis

JOURNAL OF CANCER

IF3.2

2016-01-0137

OAAI

TGF-β Induces Degradation of PTHrP Through Ubiquitin-Proteasome System in Hepatocellular Carcinoma

Tgf-β 通过泛素-蛋白酶体系统诱导肝癌PTHrP降解

JOURNAL OF CANCER

IF3.2

2015-01-0117

OAAI

Recent advances in bone-targeted therapies of metastatic prostate cancer

转移性前列腺癌的骨靶向治疗进展

CANCER TREATMENT REVIEWS

IF10.5

2014-07-0161

OAAI

Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2007-10-2634

OAAI

Guangchun He

个人简介

教育背景

工作经历

荣誉奖项

研究方向